ZA9610405B - New crystal modification of cdch a process for its preparation and pharmaceutical formulations comprising this modification - Google Patents

New crystal modification of cdch a process for its preparation and pharmaceutical formulations comprising this modification

Info

Publication number
ZA9610405B
ZA9610405B ZA9610405A ZA9610405A ZA9610405B ZA 9610405 B ZA9610405 B ZA 9610405B ZA 9610405 A ZA9610405 A ZA 9610405A ZA 9610405 A ZA9610405 A ZA 9610405A ZA 9610405 B ZA9610405 B ZA 9610405B
Authority
ZA
South Africa
Prior art keywords
modification
cdch
preparation
pharmaceutical formulations
new crystal
Prior art date
Application number
ZA9610405A
Other languages
English (en)
Inventor
Alfons Grunenberg
Patrick Bosche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA9610405(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA9610405B publication Critical patent/ZA9610405B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9610405A 1995-12-12 1996-12-11 New crystal modification of cdch a process for its preparation and pharmaceutical formulations comprising this modification ZA9610405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ZA9610405B true ZA9610405B (en) 1997-06-23

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610405A ZA9610405B (en) 1995-12-12 1996-12-11 New crystal modification of cdch a process for its preparation and pharmaceutical formulations comprising this modification

Country Status (42)

Country Link
US (1) US5849752A (cs)
EP (1) EP0780390B1 (cs)
JP (1) JP4104687B2 (cs)
KR (1) KR100525146B1 (cs)
CN (1) CN1061348C (cs)
AR (1) AR005009A1 (cs)
AT (1) ATE221531T1 (cs)
AU (1) AU708006B2 (cs)
BG (1) BG62258B1 (cs)
BR (1) BR9605968A (cs)
CA (1) CA2192418C (cs)
CO (1) CO4480105A1 (cs)
CU (1) CU22774A3 (cs)
CZ (1) CZ288657B6 (cs)
DE (2) DE19546249A1 (cs)
DK (1) DK0780390T3 (cs)
EE (1) EE03474B1 (cs)
ES (1) ES2179910T3 (cs)
HR (1) HRP960558B1 (cs)
HU (1) HU226521B1 (cs)
ID (1) ID22625A (cs)
IL (1) IL119795A (cs)
IN (1) IN185805B (cs)
MA (1) MA24342A1 (cs)
MY (1) MY117492A (cs)
NL (1) NL300109I1 (cs)
NO (1) NO306725B1 (cs)
NZ (1) NZ299905A (cs)
PL (1) PL184885B1 (cs)
PT (1) PT780390E (cs)
RO (1) RO119782B1 (cs)
RU (1) RU2162468C2 (cs)
SA (1) SA96170492B1 (cs)
SG (1) SG47201A1 (cs)
SI (1) SI0780390T1 (cs)
SK (1) SK282805B6 (cs)
SV (1) SV1996000109A (cs)
TR (1) TR199600970A2 (cs)
TW (1) TW411340B (cs)
UA (1) UA35638C2 (cs)
YU (1) YU49485B (cs)
ZA (1) ZA9610405B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999015172A1 (de) 1997-09-25 1999-04-01 Bayer Aktiengesellschaft Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
ATE279193T1 (de) * 1998-11-10 2004-10-15 Bayer Healthcare Ag Pharmazeutische zubereitung von moxifloxacin
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
AU2003278418A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Amorphous moxifloxacin hydrochloride
CA2521398C (en) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
WO2005012285A1 (en) * 2003-08-05 2005-02-10 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
EP1685130B1 (en) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
PL2032521T3 (pl) 2006-06-27 2010-05-31 Sandoz Ag Nowy sposób wytwarzania soli
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
NZ576929A (en) * 2006-11-13 2012-07-27 Cipla Ltd Crystalline anhydrous form C of moxifloxacin hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
CN102176902B (zh) 2008-10-09 2012-10-31 阿卜迪易卜拉欣贸易公司 有机溶剂在莫西沙星湿法造粒中的应用
WO2010052726A1 (en) * 2008-11-06 2010-05-14 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
US20110293717A1 (en) 2008-12-08 2011-12-01 Ratiopharm Gmbh Compacted moxifloxacin
CA2762022A1 (en) 2009-05-15 2010-11-18 Redx Pharma Limited Redox drug derivatives
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
CA2893534A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
FI871419L (fi) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
TW209865B (cs) 1992-01-10 1993-07-21 Bayer Ag
KR100228572B1 (ko) * 1992-01-31 1999-11-01 이병언 퀴놀론카르복실산 유도체 수화물 결정
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DK0676199T3 (da) * 1994-04-07 1999-02-08 Pfizer Anvendelse af trovafloxacin eller derivater deraf til fremstilling af et medikament til behandling af H. pylori-infektione

Also Published As

Publication number Publication date
CU22774A3 (es) 2002-07-24
NO965298L (no) 1997-06-13
DE59609501D1 (de) 2002-09-05
SK282805B6 (sk) 2002-12-03
NZ299905A (en) 1998-09-24
BG101043A (en) 1998-04-30
HUP9603428A3 (en) 1997-10-28
EE9600201A (et) 1997-06-16
NO306725B1 (no) 1999-12-13
CA2192418C (en) 2001-06-12
DK0780390T3 (da) 2002-11-11
ID22625A (id) 1999-12-02
CN1061348C (zh) 2001-01-31
TR199600970A2 (tr) 1997-06-21
EE03474B1 (et) 2001-08-15
NO965298D0 (no) 1996-12-11
HRP960558B1 (en) 2002-04-30
JPH09169757A (ja) 1997-06-30
HU9603428D0 (en) 1997-01-28
US5849752A (en) 1998-12-15
DE19546249A1 (de) 1997-06-19
CZ288657B6 (cs) 2001-08-15
AR005009A1 (es) 1999-04-07
CO4480105A1 (es) 1997-07-09
BR9605968A (pt) 1998-08-18
IN185805B (cs) 2001-05-05
SI0780390T1 (en) 2002-10-31
CZ364696A3 (en) 1997-07-16
RO119782B1 (ro) 2005-03-30
AU708006B2 (en) 1999-07-29
EP0780390B1 (de) 2002-07-31
PL184885B1 (pl) 2003-01-31
SA96170492B1 (ar) 2006-05-23
BG62258B1 (bg) 1999-06-30
SV1996000109A (es) 1997-10-23
TW411340B (en) 2000-11-11
CA2192418A1 (en) 1997-06-13
AU7421696A (en) 1997-06-19
HUP9603428A2 (en) 1997-08-28
CN1160052A (zh) 1997-09-24
PL317415A1 (en) 1997-06-23
IL119795A0 (en) 1997-03-18
ATE221531T1 (de) 2002-08-15
YU65096A (sh) 1998-12-23
MX9606325A (es) 1997-10-31
MA24342A1 (fr) 1998-07-01
EP0780390A1 (de) 1997-06-25
JP4104687B2 (ja) 2008-06-18
SK159196A3 (en) 1997-10-08
KR970042550A (ko) 1997-07-24
UA35638C2 (uk) 2001-04-16
RU2162468C2 (ru) 2001-01-27
HU226521B1 (en) 2009-03-30
PT780390E (pt) 2002-11-29
IL119795A (en) 1998-12-27
ES2179910T3 (es) 2003-02-01
YU49485B (sh) 2006-08-17
HRP960558A2 (en) 1998-02-28
MY117492A (en) 2004-07-31
NL300109I1 (nl) 2003-02-03
SG47201A1 (en) 1998-03-20
KR100525146B1 (ko) 2006-01-27

Similar Documents

Publication Publication Date Title
SG47201A1 (en) New crystal modification of cdch a process for its preparation and pharmaceutical formulations comprising this modification
HUP9603112A3 (en) New pharmaceutical formulation and process for its production
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
IL117659A0 (en) Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same
AU6501296A (en) Method and apparatus of enhancing the delivery of a pharmaceutical formulation
AU3967795A (en) Method of sterilizing a pharmaceutical composition
IL124268A (en) Hypocholesterolemic (1-aryl-2-oxo-3-substituted-4-azetidinyl) phenylglucopyranose derivatives and pharmaceutical compositions containing them
IL117349A0 (en) N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
CZ129596A3 (en) Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof
IL122705A (en) 2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
ZA984266B (en) Pharmaceutical composition and process of preparation
HU903907D0 (en) Process for producing pharmaceutical preparations against endoparasites containing 3-hydroxy-benzothiophene derivative and a part of active substances
IL116771A (en) 9-Substituted 2-(2-n-alkoxyphenyl) purin-6-one compounds their preparation and pharmaceutical compositions containing them
ZA9511029B (en) Substituted 4-phenylthiazole derivatives process for their preparation and pharmaceutical compositions containing them
IL124841A (en) Pharmaceutical compositions comprising liposomal prostaglandin a method of preparing such compositions and the use of liposomal prostaglandin for said preparation
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
IL117629A (en) Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
ZA966154B (en) Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them
IL119603A (en) Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
IL117078A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them
AU1066897A (en) Pharmaceutical preparations for oral administration and process for their production
ZA9610002B (en) New compounds pharmaceutical preparations containing them and a process for the preparation thereof
HK1002139A1 (en) A pharmaceutical composition having anti-decrepit action and a process for preparation thereof